In Japan, sales of Eisai and Biogen's Alzheimer's drug begin to accelerate
Biogen and Eisai’s Alzheimer’s drug Leqembi is off to a slow start in the US. But it’s big in Japan.
On Friday, Eisai revealed in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
